Top Markets
Coin of the day
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
Ранг среди акций #33866
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Цена акции
$0.5475
Последняя синхронизация: 2026-08-14
Рыночная капитализация
$6.71M
Изменение (1 день)
5.57%
Изменение (1 год)
-
Страна
US
Торговля 20/20 Biolabs Inc. (AIDX)

Категория

История дивидендной доходности для 20/20 Biolabs Inc. (AIDX)
Дивидендная доходность (TTM) компании 20/20 Biolabs Inc. (тикер: AIDX) на 2026 составляет: 0
Средняя дивидендная доходность за последние 5 лет: 0.00%
История дивидендной доходности компании 20/20 Biolabs Inc. (AIDX) с 2026 по 2026
Дивидендная доходность на конец каждого года (TTM)
Год Дивидендная доходность Изменить
Недостаточно данных для указанных дат.
Дивидендная доходность (TTM) аналогичных компаний или конкурентов
Компания Дивидендная доходность Страна
0.74%
US
0.00%
DE
2.13%
SA
0.00%
US
0.00%
MY